Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.
Munn
D H
DH
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Cheung
N K
NK
D000328:Adult; D000912:Antibodies, Neoplasm; D000920:Antibody-Dependent Cell Cytotoxicity; D002460:Cell Line; D002470:Cell Survival; D004341:Drug Evaluation; D005434:Flow Cytometry; D006801:Humans; D007700:Kinetics; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D008545:Melanoma / Q000628:therapy; D009000:Monocytes / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D009447:Neuroblastoma / Q000276:immunology / Q000473:pathology*; D010587:Phagocytosis; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity
D000912:Antibodies, Neoplasm; D011994:Recombinant Proteins; D016173:Macrophage Colony-Stimulating Factor